Establishment of a Dedicated Inherited Cardiomyopathy Clinic: From Challenges to Improved Patients' Outcome.

Emily Smith,Paul D. Thompson,Carolyn Burke‐Martindale,Adaya Weissler‐Snir,Paul D Thompson,Carolyn Burke-Martindale,Adaya Weissler-Snir

DOI: https://doi.org/10.1161/JAHA.121.024501

IF: 6.106

2022-04-28

Journal of the American Heart Association

Abstract:Background Inherited cardiomyopathies (ICs) are relatively rare. General cardiologists have little experience in diagnosing and managing these conditions. International societies have recognized the need for dedicated IC clinics. However, only few reports on such clinics are available. Methods and Results Clinical data of patients referred to our clinic during its first 2 years for a personal or family history of (possible) IC were analyzed. A total of 207 patients from 196 families were seen; 13% of probands had their diagnosis changed. Diagnosis was most commonly altered in patients referred for possible arrhythmogenic dominant right ventricular cardiomyopathy (62.5%). A total of 90% of probands had genetic testing, of whom 27.3% harbored a likely pathogenic or pathogenic variant. Of patients with confirmed hypertrophic cardiomyopathy, 31 (28.7%) were treated for left ventricular outflow tract obstruction, including septal reduction in 13. Patients with either hypertrophic cardiomyopathy or left ventricular noncompaction and a history of atrial fibrillation were started on oral anticoagulation. Oral anticoagulation was also discussed with all patients with hypertrophic cardiomyopathy and apical aneurysm. Patients with a definite diagnosis of arrhythmogenic dominant right ventricular cardiomyopathy were started on β‐blockers and given restrictive exercise prescriptions. A total of 17 patients with hypertrophic cardiomyopathy and 5 patients with likely pathogenic or likely variants in arrhythmogenic genes received primary prevention implantable cardioverter‐defibrillators. No implantable cardioverter‐defibrillators were warranted for arrhythmogenic dominant right ventricular cardiomyopathy. A total of 76 family members from 24 families had cascade screening, 32 of whom carried the familial variant. A total of 21 members from 13 gene‐elusive families were evaluated by clinical screening, 3 of whom had positive screening. Conclusions Specialized IC clinics may improve diagnosis, management, and outcomes of patients with (possible) IC and their family members. Nonstandard Abbreviations and Acronyms ARVC arrhythmogenic dominant right ventricular cardiomyopathy DCM dilated cardiomyopathy FHSCD family history of sudden cardiac death FLNC filamin C HCM hypertrophic cardiomyopathy HVI Heart and Vascular Institute IC inherited cardiomyopathy LMNA lamin A/C LP/P likely pathogenic or pathogenic LVNC left ventricular noncompaction LVOTO left ventricular outflow tract obstruction MYBPC3 myosin‐binding protein C3 MYH7 myosin heavy chain 7 OAC oral anticoagulation PKP2 plakophilin 2 RBM20 RNA‐binding motif protein 20 TTE transthoracic echocardiogram VUS variant of uncertain significance Clinical Perspective What Is New? Specialized inherited cardiomyopathy (IC) clinics can improve diagnosis, management, and outcomes of patients with IC and their family members. What Are the Clinical Implications? There is a need for dedicated clinics for IC with appropriate personnel and expertise. Efforts should be made through continuing education for cardiologists to learn how to identify individuals and families who may benefit from referral to a dedicated IC clinic. All patients with a personal or family history -Abstract Truncated-

cardiac & cardiovascular systems